Clinical Trial

Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

Study acronym: Ova-All Care
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Theronomic Ova-All Care is a tribiotic health product aimed at improving ovarian health in people with polycystic ovarian syndrome (PCOS). In this study, a total of 16 participants with PCOS diagnosed by a gynaecologist will be invited to take Ova-All Care, two capsule once a day, for 12 weeks. Biomarkers of ovarian health will be measured at baseline, four weeks after the start of the intervention, and at the end of the intervention.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-30; most recent amendment 2025-08-22.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-07-20
Trial Details
NCT Number NCT06963840
Lead Sponsor Wellizen Australia
Conditions Polycystic Ovarian Syndrome (PCOS)
Enrollment 16 participants
Start Date 2025-05-09
Primary Completion 2025-08 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-08-29